These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10389584)

  • 1. Gross and histologic features of locally advanced breast cancer after neoadjuvant chemotherapy.
    Seno R; Sparano JA; Fineberg SA
    Anat Pathol; 1998; 3():169-80. PubMed ID: 10389584
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of pathologic complete response in women treated with preoperative chemotherapy for locally advanced breast cancer: correlation of histology, hormone receptor status, Her2/Neu, and gross pathologic findings.
    Alvarado-Cabrero I; Alderete-Vázquez G; Quintal-Ramírez M; Patiño M; Ruíz E
    Ann Diagn Pathol; 2009 Jun; 13(3):151-7. PubMed ID: 19433292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.
    Huang EH; Tucker SL; Strom EA; McNeese MD; Kuerer HM; Hortobagyi GN; Buzdar AU; Valero V; Perkins GH; Schechter NR; Hunt KK; Sahin AA; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):351-7. PubMed ID: 15890574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locally advanced breast cancer and postmastectomy radiotherapy.
    Recht A
    Surg Oncol Clin N Am; 2000 Jul; 9(3):603-20, x-xi. PubMed ID: 10853145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathological manifestation and feasibility of conservative breast surgery after effective neoadjuvant chemotherapy for breast cancer].
    Liu CP; Shi L; Li Z
    Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(18):1394-6. PubMed ID: 19094510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pure and predominantly pure intralymphatic breast carcinoma after neoadjuvant chemotherapy: an unusual and adverse pattern of residual disease.
    Rabban JT; Glidden D; Kwan ML; Chen YY
    Am J Surg Pathol; 2009 Feb; 33(2):256-63. PubMed ID: 18936689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.
    Kim R; Osaki A; Tanabe K; Toge T
    Oncol Rep; 2004 Jun; 11(6):1265-72. PubMed ID: 15138565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of patients with locally advanced breast cancer.
    Lee MC; Newman LA
    Surg Clin North Am; 2007 Apr; 87(2):379-98, ix. PubMed ID: 17498533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients.
    Garimella V; Qutob O; Fox JN; Long ED; Chaturvedi A; Turnbull LW; Drew PJ
    Eur J Surg Oncol; 2007 Mar; 33(2):157-61. PubMed ID: 17085007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
    Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
    Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant systemic therapy and the surgical management of breast cancer.
    Waljee JF; Newman LA
    Surg Clin North Am; 2007 Apr; 87(2):399-415, ix. PubMed ID: 17498534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
    Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L;
    J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy.
    Peintinger F; Symmans WF; Gonzalez-Angulo AM; Boughey JC; Buzdar AU; Yu TK; Hunt KK; Singletary SE; Babiera GV; Lucci A; Meric-Bernstam F; Kuerer HM
    Cancer; 2006 Sep; 107(6):1248-54. PubMed ID: 16862596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of induction chemo- and radiotherapy in the treatment of locally advance breast cancer].
    Voznyĭ EK; Kharchenko VP; Pan'shin GA; Gurov SN; Dobrovol'skaia NI; Galil-Ogly GA; Khmelevskiĭ EV; Alipchenko LA; Bol'shakova SA
    Vopr Onkol; 2000; 46(6):736-40. PubMed ID: 11219950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update in the treatment of locally advanced breast cancer: a multidisciplinary approach.
    Franceschini G; Terribile D; Magno S; Fabbri C; D'Alba PF; Chiesa F; Di Leone A; Masetti R
    Eur Rev Med Pharmacol Sci; 2007; 11(5):283-9. PubMed ID: 18074936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0).
    Deo SV; Bhutani M; Shukla NK; Raina V; Rath GK; Purkayasth J
    J Surg Oncol; 2003 Dec; 84(4):192-7. PubMed ID: 14756429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The significance of neoadjuvant intra-arterial chemotherapy for locally advanced breast cancer by different methods].
    Tatsuta M; Furukawa H; Masutani S; Kato H; Esumi K; Masuda N; Shimizu J; Imamura H; Ikeda M; Ishida H; Kawasaki T; Satomi T; Hoshida Y
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1546-9. PubMed ID: 11707976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.